UniProt C9K1X5
Cyclooctat-9-en-7-ol synthase (C9K1X5)
Cyclooctat-9-en-7-ol synthase (UniProt C9K1X5), EC 4.2.3.146: 21 experimental structures and 1 predicted model on GenesisL1, 7 ligands bound, 27 pockets. Binding sites, druggability and experiment against prediction (TM-score) in…
- UniProt
- C9K1X5
- Protein
- Cyclooctat-9-en-7-ol synthase
- EC
- 4.2.3.146
- Experimental structures
- 21
- Predicted models
- 1
- Ligands
- 7
- Pockets
- 27 · 5 records with a druggable one
Structures
22 records of C9K1X5 in the MolNFT archive: 21 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 4OMG | Crystal structure of the bacterial diterpene cyclase COTB2 | x-ray diffraction | A, B | — | — |
| 4OMG | Crystal structure of the bacterial diterpene cyclase COTB2 | x-ray diffraction | A, B | — | — |
| 4OMH | Crystal structure of the bacterial diterpene cyclase COTB2 variant F149L | x-ray diffraction | A, B | — | — |
| 4OMH | Crystal structure of the bacterial diterpene cyclase COTB2 variant F149L | x-ray diffraction | A, B | — | — |
| 5GUC | Crystal structure of COTB2 (apo form) from streptomyces melanosporofaciens | x-ray diffraction | A, B | — | — |
| 5GUE | Crystal structure of COTB2 (GGSPP/MG2+-bound form) from streptomyces melanosporofaciens | x-ray diffraction | A, B, C, D | — | — |
| 6GGI | Crystal structure of COTB2 in complex with 2-fluoro-3,7,18- dolabellatriene | x-ray diffraction | A, B | MG, PPV, EXW, CL, CCN, K | — |
| 6GGJ | Crystal structure of CotB2 in complex with alendronate | x-ray diffraction | A, B | AHD, MG | 5 (best 0.81) |
| 6GGJ | Crystal structure of COTB2 in complex with alendronate | x-ray diffraction | A, B | AHD, MG | — |
| 6GGK | Crystal structure of CotB2 C-terminal truncation | x-ray diffraction | A, B | MG | 5 (best 0.77) |
| 6GGK | Crystal structure of COTB2 C-terminal truncation | x-ray diffraction | A, B | MG | — |
| 6GGL | Crystal structure of CotB2 variant F107A | x-ray diffraction | A, B | MG | 4 (best 0.75) |
| 6GGL | Crystal structure of COTB2 variant F107A | x-ray diffraction | A, B | MG | — |
| 7AO0 | Crystal structure of CotB2 variant F107A in complex with alendronate | x-ray diffraction | A, B | AHD, MG, CL | 7 (best 0.83) |
| 7AO0 | Crystal structure of COTB2 variant F107A in complex with alendronate | x-ray diffraction | A, B | AHD, MG, CL | — |
| 7AO1 | Crystal structure of CotB2 variant W288F in complex with alendronate | x-ray diffraction | A, B | AHD, MG, CL | 6 (best 0.82) |
| 7AO1 | Crystal structure of COTB2 variant W288F in complex with alendronate | x-ray diffraction | A, B | AHD, MG, CL | — |
| 7AO2 | Crystal structure of COTB2 variant W288G in complex with alendronate | x-ray diffraction | A, B | AHD, MG, CL | — |
| 7AO3 | Crystal structure of COTB2 variant F149L in complex with alendronate | x-ray diffraction | A, B | AHD, MG, CL | — |
| 7AO4 | Crystal structure of COTB2 variant W288G | x-ray diffraction | A, B | — | — |
| 7AO5 | Crystal structure of COTB2 variant W288F | x-ray diffraction | A, B | MG | — |
| C9K1X5 | AlphaFold monomer V2.0 prediction for cyclooctat-9-en-7-ol synthase (C9K1X5) | predicted | A | — | — |
Ligands
Experiment against prediction
- 7AO3 chain B against the predicted model C9K1X5: TM-score 1.00, RMSD 0.20 Å
- 6GGJ chain A against the predicted model C9K1X5: TM-score 1.00, RMSD 0.25 Å
- 6GGJ chain A against the predicted model C9K1X5: TM-score 1.00, RMSD 0.25 Å
- 7AO2 chain B against the predicted model C9K1X5: TM-score 1.00, RMSD 0.46 Å
- 7AO2 chain A against the predicted model C9K1X5: TM-score 1.00, RMSD 0.46 Å
- 6GGJ chain B against the predicted model C9K1X5: TM-score 0.99, RMSD 0.29 Å
- 6GGJ chain B against the predicted model C9K1X5: TM-score 0.99, RMSD 0.29 Å
- 6GGK chain B against the predicted model C9K1X5: TM-score 0.99, RMSD 0.46 Å
- 6GGK chain B against the predicted model C9K1X5: TM-score 0.99, RMSD 0.46 Å
- 6GGL chain A against the predicted model C9K1X5: TM-score 0.99, RMSD 0.56 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.